Literature DB >> 2660700

Interleukin-6. Multiple activities in regulation of the hematopoietic and immune systems.

S C Clark1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2660700

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells.

Authors:  M D'Addario; A Roulston; M A Wainberg; J Hiscott
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

2.  Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.

Authors:  Dongwei Guo; Gang Zhang; Tadeusz A Wysocki; Beata J Wysocki; Harris A Gelbard; Xin-Ming Liu; JoEllyn M McMillan; Howard E Gendelman
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations.

Authors:  Pavan Puligujja; Shantanu S Balkundi; Lindsey M Kendrick; Hannah M Baldridge; James R Hilaire; Aditya N Bade; Prasanta K Dash; Gang Zhang; Larisa Y Poluektova; Santhi Gorantla; Xin-Ming Liu; Tianlei Ying; Yang Feng; Yanping Wang; Dimiter S Dimitrov; JoEllyn M McMillan; Howard E Gendelman
Journal:  Biomaterials       Date:  2014-12-09       Impact factor: 12.479

4.  A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.

Authors:  Alolika Nandi; Priyankar Pal; Surupa Basu
Journal:  Rheumatol Int       Date:  2019-07-13       Impact factor: 2.631

5.  Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B.

Authors:  Y Zhang; M Broser; W N Rom
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

6.  Blood cytokine levels rise even after minor surgical trauma.

Authors:  I Grzelak; W L Olszewski; M Zaleska; M Durlik; B Lagiewska; M Muszynski; W Rowinski
Journal:  J Clin Immunol       Date:  1996-05       Impact factor: 8.317

7.  Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages.

Authors:  Mariluz Araínga; Dongwei Guo; Jayme Wiederin; Pawel Ciborowski; JoEllyn McMillan; Howard E Gendelman
Journal:  Retrovirology       Date:  2015-01-22       Impact factor: 4.602

8.  Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.

Authors:  Prabagaran Narayanasamy; Barbara L Switzer; Bradley E Britigan
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

9.  Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.

Authors:  Benson J Edagwa; Dongwei Guo; Pavan Puligujja; Han Chen; JoEllyn McMillan; Xinming Liu; Howard E Gendelman; Prabagaran Narayanasamy
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

10.  Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.

Authors:  Dongwei Guo; Tian Zhou; Mariluz Araínga; Diana Palandri; Nagsen Gautam; Tatiana Bronich; Yazen Alnouti; JoEllyn McMillan; Benson Edagwa; Howard E Gendelman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.